CA -
JP
Choose Your Language
English
Français
日本語
English US
Dutch
Deutsch
ABOUT US
PATIENTS & CAREGIVERS
MEDICAL PROFESSIONALS
INVESTORS
MEDIA
Financial Information
Key figures
Financial Reports and Presentations
Press releases
Investor newsletter
Press releases
Share information
Share information
Analyst coverage
Shareholder structure
Other Financial Information
Corporate Governance
Board Members
Executive Team
Organizational Regulations
Annual General Meeting
Financial calendar
CA -
JP
|
|
Choose Your Language
English
Français
日本語
English US
Dutch
Deutsch
ABOUT US
CORPORATE
VISION
INNOVATION
EDUCATION
MANUFACTURING
QUALITY
LOCATIONS
HISTORY
HEALTHCARE SYSTEM SUSTAINABILITY
VALUES
#BEMEDACTA STORIES
COMPLIANCE
CODE OF BUSINESS CONDUCT AND ETHICS
CORPORATE COMPLIANCE PROGRAMME
ACADEMY
CAREERS
FOUNDATION
PATIENTS & CAREGIVERS
KNEE REPLACEMENT
HIP REPLACEMENT
SHOULDER REPLACEMENT
SPINE SURGERY
MEDICAL PROFESSIONALS
JOINT
HIP
AMIS
PRIMARY TOTAL HIP REPLACEMENT
FEMORAL SYSTEMS
AMISTEM SYSTEM
QUADRA SYSTEM
X-ACTA
FEMORAL HEADS
ACETABULAR SYSTEMS
VERSAFITCUP CC TRIO
VERSAFITCUP DM
CEMENTED CUPS
VERSACEM
REVISION TOTAL HIP REPLACEMENT
REVISION FEMORAL SYSTEMS
QUADRA SYSTEM
HEMIARTHROPLASTY
BIPOLAR HEAD
ENDO HEAD
FEMORAL SYSTEMS
AMISTEM SYSTEM
QUADRA SYSTEM
TECHNOLOGIES
HIGHCROSS
KNEE
TOTAL KNEE SYSTEMS
GMK SPHERE
GMK PRIMARY
OTHER IMPLANTS
EVOLIS
TECHNOLOGIES
MYKNEE
MYKNEE MIS
GMK EFFICIENCY
PATIENT-MATCHED TECHNOLOGY
MYKNEE
MYKNEE MIS
SINGLE USE INSTRUMENTS
GMK EFFICIENCY
NEXTAR
SHOULDER
MEDACTA SHOULDER SYSTEM
MYSHOULDER
NEXTAR SHOULDER
SPORTS MED
MYSOLUTIONS
EDUCATION
M.O.R.E. INSTITUTE
M.O.R.E. APP
M.O.R.E. EDUCATION PROGRAMS
HOW TO START WITH AMIS
HOW TO MASTER AMIS
EDUCATION KNEE PROGRAM
EDUCATION SPINE PROGRAM
ASK FOR A COURSE
EVENTS
M.O.R.E. PUBLICATIONS
CHANNELS
SUPPORT & SERVICES
MYPRACTICE
RESOURCES
INSTRUMENTS
CLEANING, DECONTAMINATION AND STERILIZATION
USE AND HANDLING
PRODUCTS COMPATIBILITY
HIP COMPATIBILITY
NEWS
CONGRESSES
COMPLIANCE
INVESTORS
Financial Information
Key figures
Financial Reports and Presentations
Press releases
Investor newsletter
Press releases
Share information
Share information
Analyst coverage
Shareholder structure
Other Financial Information
Corporate Governance
Board Members
Executive Team
Organizational Regulations
Annual General Meeting
Financial calendar
MEDIA
PRESS RELEASE
MEDIA KIT
SOCIAL MEDIA
CONTACT US
Analyst coverage
The following analysts evaluate the performance of Medacta stock and the investment opportunities for investors.
BERENBERG
Sam England, CFA
60 Threadneedle St
London EC2R 8HP
Phone: +44 20 34652687
sam.england@berenberg.com
MIRABAUD
Dr. Anja Pomrehn
29, Boulevard Georges-Favon
1204 Geneva
Phone: +41 44 7982468
anja.pomrehn@mirabaud-msl.com
MORGAN STANLEY
Robert J Davies, Ph.D.
25 Cabot Square, Canary Wharf
London E14 4QA
Phone: +44 20 7425-2057
Robert.J.Davies@morganstanley.com
OCTAVIAN AG
Ms. Sandra Dietschy, PhD
Hottingerstrasse 12
CH-8032 Zürich
Phone: +41 44 518 08 27
sandra.dietschy@octavian.ch
Research Partners AG
Mr. Alexander Burgansky, CFA
Hottingerstrasse 12
CH-8032 Zürich
Phone: +41 44 533 40 30
alexander.burgansky@researchpartners.ch
Stifel
Mr. Dylan van Haaften
150 Cheapside,
London EC2V 6ET
Phone: +44 (20) 7710 7462
dylan.vanhaaften@stifel.com
UBS
Mr. Graham Doyle
5 Broadgate
London EC2M 2QS
Phone: +44 20 7568 2587
graham.doyle@ubs.com
Zürcher Kantonalbank
Mr. Edouard Riva
Bahnhofstrasse 9
8010 Zurich
Phone: +41 44 292 20 05
edouard.riva@zkb.ch
INVESTORS
Share information
Analyst coverage
Reserved Area
Legal Policy
Privacy & Cookie Policy